The content of alkaline phosphatase (ALP) was determined in neutrophils isolated from patients with acute bacterial infections by a standard enzyme assay. Compared with control cells, patient cells exhibited about a fivefold increase in ALP activity. There was no difference between the ALP K m values of control and patient cells, which indicates that the elevated activity in patient cells was due to the presence of increased amounts of the enzyme. The ALP isozyme in both cell types was determined to be the tissue-unspecific ALP. The fact that much of the ALP activity was measurable only in the presence of detergent suggested that the enzyme was localized in the secretory vesicles, a putative reservoir of plasma membrane components. The amount and subcellular distribution of two other secretory vesicle membrane proteins, i.e., cytochrome b and complement receptor 3, were not altered; hence, we conclude that there was no general increase in amounts of secretory vesicle membrane constituents in the patient cells.
The outcome of a bacterial infection is greatly dependent on the function of the neutrophil granulocytes. The ability to seek, seize, engulf, and subsequently kill invading microbes is dependent on neutrophil functions such as cell locomotion (chemotaxis), phagocytosis, and activation of bactericidal enzyme systems (16, 21) . During a bacterial infection, substances that may influence the neutrophil to activate these functions are produced. Bacterial products, colony-stimulating factors, endogenous pyrogens, and components of the complement system are among the substances that influence neutrophil function (16) . A characteristic response of neutrophils to bacterial infections is the pronounced increase in alkaline phosphatase (ALP) activity (26, 33, 37) . After the onset of an infection, the ALP activity in neutrophils rises rapidly (within hours) to a level that is severalfold higher than that seen in neutrophils from healthy individuals. The nature and purpose of this activity increase are not known.
Human ALP is a phosphatidylinositol-linked membrane glycoprotein (27) that exists in at least four isoforms and is present in many different cell types and tissues, including the neutrophils (34) . ALP is known to catalyze phosphoprotein phosphatase activities as well as transphosphorylations, but the biological significance of the enzyme has not been established. Nonetheless, ALP has been suggested to be involved in bone calcification (27) , phosphate transport in intestinal epithelial cells (18) , and transport of immunoglobulins across the placenta (24) .
In the neutrophils of healthy individuals, ALP is localized mainly in the secretory vesicles, the most easily mobilized storage organelles in the neutrophil (2, 30) . The secretory vesicles constitute a specialized form of endocytic vesicle that is formed during neutrophil maturation. In addition to ALP, the secretory vesicle membrane contains the complement receptor 3 (CR3, Mac-1) (29) and receptors for chemotactic formylated peptides (31) . The fact that secretory vesicles contain chemotactic receptors and adhesion molecules indicates that these storage organelles are essential for the transition of neutrophils from L-selectin to Mac-1-presenting cells, a prerequisite for firm adhesion to endothelium and for diapedesis (4) .
In the present study, we determined the activity and subcellular localization of ALP in neutrophils isolated from patients suffering from severe bacterial infections. We found an increased expression of ALP in the plasma membrane and in the secretory vesicles. To elucidate the specificity of the ALP increase, that is, to find out whether there was an increase in ALP only or if there was a general increase in neutrophil secretory vesicle membrane proteins, we examined the contents of cytochrome b (the NADPH-oxidase membrane component) and CR3 in the cells isolated from patients. We found that patient and control neutrophils contained equal amounts of both cytochrome b and CR3.
MATERIALS AND METHODS

Isolation of neutrophils.
Heparinized peripheral blood samples were obtained from 21 patients with clinical and laboratory signs of acute bacterial infection. The samples were drawn early after admission to hospital and before confirmation of exact bacterial etiology. In the patient group, 11 individuals were suffering from pneumonia (etiology, five Streptococcus pneumoniae, one Moraxella catarrhalis, five not defined), 4 from sepsis (etiology, one Klebsiella pneumoniae, one Escherichia coli, two not defined because of antibiotic treatment), 3 from erysipelas (etiology, Streptococcus pyogenes), 2 from pyelonephritis (etiology, E. coli), and 1 from meningitis (etiology, S. pneumoniae). The patients ranged in age from 20 to 88 years (mean ϭ median ϭ 62 years). Informed consent was obtained from the patients, and the study was approved by the Ethics Committee of the Medical Faculty of the University of Linköping. Blood samples obtained from non-age-matched and apparently healthy donors were used as controls. Neutrophils were isolated as described by Böyum (8) , washed twice, and resuspended in Krebs-Ringer phosphate buffer or in disruption buffer (see below). After isolation, the cells were stored at 4ЊC and used within 1 h of preparation. The number of patients and controls in the different experimental setups are given in Table 1 .
Determination of ALP activity. ALP activity was measured by hydrolysis of p-nitrophenyl phosphate (PNPP; 3.5 mM) at pH 10.5 in a sodium-barbital buffer (12) . Cells or subcellular fractions were added to a buffer solution with or without Triton X-100 (0.2% final concentration) and containing the substrate. After incubation of the mixture at 37ЊC for 45 min, the reaction was terminated by adding ice-cold buffer, and the A 410 was measured. The ALP activity was calculated by use of an extinction coefficient of 18.6 mM Ϫ1 cm Ϫ1 for p-nitrophenol; 1 U of enzyme liberates 1 mol of product per min. In some experiments, the substrate concentration was varied (from 0.09 to 9 mM) and the initial rate of the absorbance change was determined. The Michaelis constant (K m ) was calculated from plots of the initial velocity as a function of substrate concentration.
To investigate the heat stability of neutrophil ALP, the cells were incubated at 56ЊC for 30 min before enzyme activity was measured.
ALP isozymes (tissue unspecific [AP] and intestinal [IAP] ) were determined by monoclonal immunocatalytic assays as described in detail by Hirano et al. (19) . In short, monoclonal antibodies against AP and IAP were coupled covalently to cyanogen bromide-activated paper discs. The discs were incubated with the sample for 3 h, washed three times, and then incubated for 30 min in substrate solution containing disodium phenylphosphate. The enzyme reaction was stopped by the addition of 0.2 M boric acid solution, and the A 500 was measured.
Subcellular fractionation. Neutrophils were resuspended in ice-cold disruption buffer [KCl, 100 mM; NaCl, 3 mM; MgCl 2 , 3.5 mM; ATP, 1 mM; piperazine-N,N-bis(2-ethanesulfonic acid), 10 mM; pH 7.4] and disrupted by nitrogen cavitation (Parr Instrument Company, Moline, Ill.). The postnuclear supernatant was centrifuged on a two-layer Percoll gradient as described by Borregaard et al. (3) . The gradient, which contained three visible bands corresponding to the azurophil granules (␣ band), the specific granules (␤ band), and the plasma membranes and secretory vesicles (␥ band), was collected by successive aspiration of 1.5-ml gradient fractions from the bottom of the centrifuge tube.
Markers for subcellular fractions. Vitamin B 12 -binding protein was determined by the cyanocobalamin technique as described by Gottlieb et al. (17) .
The myeloperoxidase and cytochrome b contents of the gradient fractions were determined from absorption spectra (400 to 600 nm) (7) . In short, samples were diluted in disruption buffer containing Triton X-100 (0.2% final concentration), and each diluted sample was divided into two portions which were placed in separate plastic cuvettes. The samples were scanned to obtain a baseline (oxidized state) and then rescanned after adding a few grains of sodium dithionite to one of the cuvettes to obtain the spectral difference between the oxidized and the reduced states. The amount of cytochrome b was calculated from the spectra by use of an extinction coefficient of 106 mM Ϫ1 cm Ϫ1 for the 427-nm peak.
Mobilization of secretory vesicles. Neutrophils were preincubated for 10 min at 37ЊC and then stimulated with the chemoattractant formylmethionyl-leucylphenylalanine (fMLP; 10 Ϫ7 M). The stimulation was terminated after 10 min by adding 3 volumes of ice-cold physiological saline. For fractionation, the cells were sedimented by centrifugation, resuspended in ice-cold disruption buffer, and fractionated on discontinuous Percoll gradients as described above.
Expression of CR3. The expression of CR3 in resting and fMLP-stimulated neutrophils was analyzed in parallel in patient and control neutrophils within 4 h of drawing the blood samples. Ten microliters of phycoerythrin-conjugated mouse monoclonal anti-CR3 antibody of the immunoglobulin G2 class was added to neutrophil pellets (ca. 10 6 cells). The cells were then incubated at 4ЊC for 30 min, washed twice, and resuspended in phosphate-buffered saline-EDTA (23) . The immunostained cells were examined in a flow cytometer (FACS Scan; Becton Dickinson, Mountain View, Calif.) to determine the mean fluorescence intensity.
Statistical analysis. Significance was defined by the two-tailed t test (unpaired). P values exceeding 0.05 were considered not significant.
Reagents. ATP, PNPP, fMLP, and Triton X-100 were obtained from Sigma Chemical Co., St. Louis, Mo. Dextran, Ficoll-Paque, and Percoll were from Pharmacia (Uppsala, Sweden). Phycoerythrin-conjugated mouse monoclonal anti-CR3 antibody was purchased from Becton Dickinson. The 57 Co-labeled vitamin B 12 was supplied by Amersham Laboratories (Amersham, Buckinghamshire, England). Monoclonal antibodies against AP and IAP were prepared as described previously (19) .
RESULTS
ALP activity. Neutrophils from patients with acute bacterial infections had a much larger capacity to hydrolyze the ALP substrate PNPP than control neutrophils did (Table 1) . Theoretically, this increased capacity could have been due to an activity-increasing modification of the enzyme. However, since the K m of the enzyme was of the same magnitude in the two cell types (Table 1) , the increased activity of the patient cells reflects an increased amount of enzyme.
Subcellular localization and latency of ALP. Normal neutrophils were disrupted by nitrogen cavitation and fractionated on discontinuous Percoll density gradients. Three distinct and well-separated bands were visible on the gradients, and the distribution of myeloperoxidase, vitamin B 12 -binding protein, and ALP, markers for the azurophil granules, the specific granules, and plasma membrane and secretory vesicles, respectively, is shown in Fig. 1 . This pattern with three distinct bands (designated ␣, ␤, and ␥, in order of decreasing density) was also obtained with cells isolated from patients with bacterial infections (data not shown).
The secretory vesicles cannot be separated from the plasma membrane by means of density gradient centrifugation. However, the presence of secretory vesicles in normal cells can be determined by the latency of the ALP activity, i.e., the difference in enzyme activity obtained when separate measurements are made in the absence and presence of a detergent (6) . In normal, resting neutrophils, about 80% of the ALP was present in the secretory vesicles (Fig. 2a) . The latency was also obvious in the patient cells, although it varied between 35 and 65% ( Fig. 2b and c The postnuclear supernatant was centrifuged on a two-layer Percoll gradient, and 1.5-ml gradient fractions were collected successively from the bottom of the centrifuge tube. Enzyme assays were performed on these gradient fractions to determine the localization of membranes and organelles in the gradient. Myeloperoxidase, vitamin B 12 -binding protein, and ALP are markers for the azurophil granules (␣), the specific granules (␤), and the plasma membrane and secretory vesicles (␥), respectively. ALP was measured in the presence of Triton X-100. The contents of marker molecules are expressed as follows: optical density (ϫ167) for myeloperoxidase; counts per minute (ϫ0.001) for vitamin B 12 -binding protein; optical density (ϫ1) for ALP. latent activity (Fig. 3) further strengthens the conclusion that latent neutrophil ALP is located in the easily mobilized secretory vesicles of patient cells. ALP isozymes. The human ALPs are a group of four related isozymes: the tissue-unspecific (i.e., AP), intestinal (i.e., IAP), placental, and placental ALP-like ALPs (34) . The catalytic activity of the placental isozyme is heat stable, whereas that of AP and IAP is not. Heat treatment of the neutrophils resulted in a loss of all ALP activity (Table 1) ; hence, we conclude that the enzyme present in neutrophils is of either the AP or IAP isotype. Using the isozyme-specific monoclonal antibodies against these two isozymes, we showed that both control and patient cells contained the AP isozyme (Fig. 4) , whereas no IAP could be detected (data not shown). This is in accordance with the results of inhibition studies (15, 32) . Subcellular localization of cytochrome b. In resting neutrophils, the membrane component of the respiratory burst oxidase, i.e., cytochrome b, has been found in two subcellular locations, namely, the specific granules (80%) and the secretory vesicles and plasma membrane (20%), as indicated by respective distribution in the ␤ and the ␥ bands obtained on a Percoll gradient (3) . The fact that all oxidase activity in the ␥ band colocalizes with the secretory vesicles (30) indicates that the membrane oxidase component is a constituent of these organelles. We investigated the subcellular distribution of the cytochrome b in neutrophils from two of the patients with bacterial infections. The distribution was the same as that in control cells, i.e., we found that most of the cytochrome was recovered in the specific granules, whereas a smaller part (20% in control cells and 23% in patient cells) was found in the ␥ band containing the plasma membrane and secretory vesicles (Fig. 5) . The total amount of cytochrome b in patient neutrophils was not significantly different from the amount in normal neutrophils (Table 1) . These results indicate that there was no general increase in the amounts of secretory vesicle membrane components in these cells. 
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Up-regulation of CR3. It has been reported that 20% of the CR3 is localized in the secretory vesicles and 5% is localized in the plasma membrane; the remaining 75% is localized in the specific granules (29) . Mobilization of the secretory vesicles by stimulation with fMLP is associated with the up-regulation of CR3 to the plasma membrane, as shown in Fig. 6 . We found that the amount and distribution of CR3 before and after up-regulation were similar in control and patient cells (Fig. 6,  insets) , which strengthens the conclusion that although there was an increase in ALP, there was no general increase in the amounts of secretory vesicle membrane constituents. The slightly larger amount of plasma membrane-localized CR3 seen in unstimulated patient cells, compared with that in control cells, probably reflects a mobilization of the secretory vesicles which is also seen as a lower ALP latency (Fig. 2) .
DISCUSSION
Although the precise role of ALP in neutrophil function is unknown, it is known that the ALP activity increases in neutrophils isolated from patients suffering from bacterial infections (26, 33, 37) . This inspired us to investigate the nature and subcellular localization of ALP in these cells. We found that neutrophils from both healthy blood donors and patients with infections contained the same type of ALP isozyme, i.e., the tissue-unspecific ALP isozyme, AP. This confirms the results of inhibition studies (15, 32) . Theoretically, the increase in phosphatase activity in patient cells could be due to an increased amount of enzyme or to an activity-increasing modification of the enzyme molecule. Since there was no difference between the K m values of the enzyme present in normal neutrophils and that in patient neutrophils, we conclude that the increased activity was due to the presence of an increased amount of the enzyme.
Most of the ALP activity of human neutrophils is localized in the secretory vesicles, organelles that can be translocated to the plasma membrane during cell stimulation (2, 6, 22) . We found that much of the ALP activity in patient cells was latent (i.e., measurable only in the presence of detergent), which suggests that the enzyme was localized in the secretory vesicles in these cells as well; this assumption was confirmed by subcellular fractionation and mobilization studies.
Several investigators have reported that neutrophils isolated from patients with severe bacterial infections are metabolically primed (9, 14, 25, 26, 35) . The molecular background of the primed state is not known, but the primed state has been suggested to be due to an up-regulation of cell surface receptors (11, 13, 14) . Both indirect and direct evidence defines the secretory vesicles as storage organelles that contain a reserve pool of receptors that are exposed on the cell surface during neutrophil diapedesis (1, 2, 10, 36) . It is tempting to suggest that translocation of the membrane components from the secretory vesicles to the plasma membrane is one of the mechanisms involved in neutrophil priming. The presence of cells with mobilized secretory vesicles (observed as low or no latency of the neutrophil ALP) in the circulation may be of importance in the development of the tissue damage sometimes associated with a severe bacterial disease. In our study, the fraction of ALP present in the secretory vesicles varied between 35 and 65% in the patient group (compared with 80% in control cells), i.e., the secretory vesicles of the patient cells had been degranulated and the storage pool of surface receptors had been mobilized to various extents. Whether this mobilization correlates with the state of priming remains to be investigated.
Bacterial infections are often associated with an enhanced myelopoietic activity and increased levels of the granulocyte colony-stimulating factor (G-CSF) (20) . It has been shown that ALP production (as well as priming) in neutrophils is induced by G-CSF (28) and that an increase in G-CSF may, in turn, cause a rise in ALP activity (as well as of priming effects) seen in patient neutrophils. The NADPH oxidase of professional phagocytes has been regarded to be a plasma membrane-bound electron transport system. However, it has been shown recently that most of the membrane-associated oxidase component (cytochrome b) is localized in the specific granules (approximately 80%) and the rest is present in a light-membrane fraction that colocalizes with the secretory vesicles (30) . In our experiments, the total amount of cytochrome b and the distribution of the protein in the subcellular fractions of patient and control cells were found to be equivalent. These results indicate that no general increase in the number of secretory vesicles or membrane constituents of secretory vesicles had occurred in patient neutrophils. This was confirmed by the results obtained when measuring expression of CR3 in control and patient cells. We found that mobilization of secretory vesicles resulted in equal (or in patient cells somewhat lower) levels of expression of CR3 in both cell types. The slightly larger amount of CR3 in nonstimulated patient cells, compared with that in control cells, was probably caused by a mobilization of the secretory vesicles, which also explains the decrease in latency of ALP. A selective increase in ALP activity has also been seen in neutrophils isolated from patients suffering from myeloproliferative disorders (5) . Furthermore, in agreement with our results on neutrophils isolated from patients with bacterial infections, the cells in the cited study (5) showed normal levels of both cytochrome b and CR3 while the ALP activity was dramatically increased.
In conclusion, we found that ALP in neutrophils from patients with bacterial infections exhibited the same features as control cell ALP in terms of isoform, subcellular distribution, and mobilization. However, the total activity was substantially increased in the patient cells because of an increase in the amount of enzyme present. Since the levels of two other secretory vesicle membrane proteins, i.e., cytochrome b and CR3, were not altered, we conclude that there was no general increase in the amounts of secretory vesicle constituents.
